Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by XIU-HONG JIA
Timosaponin A-Iii Reverses Multi-Drug Resistance in Human Chronic Myelogenous Leukemia K562/Adm Cells via Downregulation of MDR1 and MRP1 Expression by Inhibiting PI3K/Akt Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Related publications
TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Downregulation of NEAT1 Reverses the Radioactive Iodine Resistance of Papillary Thyroid Carcinoma Cell via miR-101-3p/FN1/PI3K-AKT Signaling Pathway
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Diosgenin Inhibits Cell Proliferation of Primary Human Thyrocytes via Downregulation of PI3K/Akt Signaling Pathway
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Downregulation of BAG‑1 in T47D Cells Promotes Resistance to Tamoxifen via Activation of the PI3K/Akt/mTOR Signaling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
Retraction: Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-Gp and MRP1
PLoS ONE
Multidisciplinary
ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Wogonin Reversed Resistant Human Myelogenous Leukemia Cells via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation
Scientific Reports
Multidisciplinary
SIRT2 Mediates Multidrug Resistance in Acute Myelogenous Leukemia Cells via ERK1/2 Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Inhibitor of DNA Binding 3 Reverses Cisplatin Resistance in Human Lung Adenocarcinoma Cells by Regulating the PI3K/Akt Pathway
Oncology Letters
Cancer Research
Oncology
